| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 10,953,460 | |||
| Prepaid expenses | 332,301 | |||
| Supplies used for r&d and manufacturing | 303,282 | |||
| Deposit | 7,085 | |||
| Total current assets | 11,596,128 | |||
| Finance lease right-of-use assets | 5,548,186 | |||
| Operating lease right-of-use assets | 1,274,780 | |||
| Property and equipment, net | 6,079,295 | |||
| Patent costs, net | 119,856 | |||
| Deposits | 2,319,101 | |||
| Supplies used for r&d and manufacturing, noncurrent | 1,218,402 | |||
| Total assets | 28,155,748 | |||
| Accounts payable | 1,061,351 | |||
| Accrued expenses | 711,820 | |||
| Due to employees | 916,588 | |||
| Finance lease liabilities, current portion | 2,273,797 | |||
| Operating lease liabilities, current portion | 166,990 | |||
| Total current liabilities | 5,130,546 | |||
| Finance lease liabilities, net of current portion | 5,684,127 | |||
| Operating lease liabilities, net of current portion | 1,258,990 | |||
| Other liabilities | 125,000 | |||
| Total liabilities | 12,198,663 | |||
| Common stock, 0.01 par value 600,000,000 shares authorized 5,321,341 and 2,126,237 shares issued and outstanding at june 30, 2025 and september 30, 2024, respectively | 80,157 | |||
| Additional paid-in capital | 555,299,844 | |||
| Accumulated deficit | -539,422,916 | |||
| Total stockholders' equity | 15,957,085 | |||
| Total liabilities and stockholders' equity | 28,155,748 | |||
CEL SCI CORP (CVM)
CEL SCI CORP (CVM)